AIC
AGTC

Ameritas Investment Company’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Ameritas Investment Company’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$1.52K – 2220
2021
Q1 		$1.52K Buy
+300
New +$1.56K ﹤0.01% 1983
2020
Q2 		– Sell
-300
Closed -$1K – 1724
2020
Q1 		$1K Buy
+300
New +$1.58K ﹤0.01% 1728

Other funds holding AGTC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Ameritas Investment Company's AGTC Position: Q2 2021 in Review

Ameritas Investment Company sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 300 shares — an estimated $1.52K sold.

Ameritas Investment Company first reported a position in AGTC in Q1 2020 and held it in 2 quarters. The position peaked at $1.52K in Q1 2021. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Ameritas Investment Company reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 300 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $1.52K.
  • Ameritas Investment Company first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 2 quarters.
  • Ameritas Investment Company's Applied Genetic Technologies Corporation position peaked at $1.52K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.